Literature DB >> 23267081

Mice with an adipocyte-specific lipin 1 separation-of-function allele reveal unexpected roles for phosphatidic acid in metabolic regulation.

Mayurranjan S Mitra1, Zhouji Chen, Hongmei Ren, Thurl E Harris, Kari T Chambers, Angela M Hall, Karim Nadra, Samuel Klein, Roman Chrast, Xiong Su, Andrew J Morris, Brian N Finck.   

Abstract

Lipin 1 is a coregulator of DNA-bound transcription factors and a phosphatidic acid (PA) phosphatase (PAP) enzyme that catalyzes a critical step in the synthesis of glycerophospholipids. Lipin 1 is highly expressed in adipocytes, and constitutive loss of lipin 1 blocks adipocyte differentiation; however, the effects of Lpin1 deficiency in differentiated adipocytes are unknown. Here we report that adipocyte-specific Lpin1 gene recombination unexpectedly resulted in expression of a truncated lipin 1 protein lacking PAP activity but retaining transcriptional regulatory function. Loss of lipin 1-mediated PAP activity in adipocytes led to reduced glyceride synthesis and increased PA content. Characterization of the deficient mice also revealed that lipin 1 normally modulates cAMP-dependent signaling through protein kinase A to control lipolysis by metabolizing PA, which is an allosteric activator of phosphodiesterase 4 and the molecular target of rapamycin. Consistent with these findings, lipin 1 expression was significantly related to adipose tissue lipolytic rates and protein kinase A signaling in adipose tissue of obese human subjects. Taken together, our findings identify lipin 1 as a reciprocal regulator of triglyceride synthesis and hydrolysis in adipocytes, and suggest that regulation of lipolysis by lipin 1 is mediated by PA-dependent modulation of phosphodiesterase 4.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23267081      PMCID: PMC3545773          DOI: 10.1073/pnas.1213493110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.

Authors:  Young Hun Choi; Sunhee Park; Steven Hockman; Emilia Zmuda-Trzebiatowska; Fredrik Svennelid; Martin Haluzik; Oksana Gavrilova; Faiyaz Ahmad; Laurent Pepin; Maria Napolitano; Masato Taira; Frank Sundler; Lena Stenson Holst; Eva Degerman; Vincent C Manganiello
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

2.  Control of fat cell phosphohydrolase by lipolytic agents.

Authors:  F Moller; K H Wong; P Green
Journal:  Can J Biochem       Date:  1981-01

3.  Relationships between phosphatidic acid and cyclic nucleotide phosphodiesterases in activated human blood mononuclear cells.

Authors:  A Zakaroff-Girard; S El Bawab; G Némoz; M Lagarde; A F Prigent
Journal:  J Leukoc Biol       Date:  1999-03       Impact factor: 4.962

4.  Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.

Authors:  Brian N Finck; Matthew C Gropler; Zhouji Chen; Teresa C Leone; Michelle A Croce; Thurl E Harris; John C Lawrence; Daniel P Kelly
Journal:  Cell Metab       Date:  2006-09       Impact factor: 27.287

5.  Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1.

Authors:  Thurl E Harris; Todd A Huffman; An Chi; Jeffrey Shabanowitz; Donald F Hunt; Anil Kumar; John C Lawrence
Journal:  J Biol Chem       Date:  2006-11-14       Impact factor: 5.157

6.  The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities.

Authors:  C A Langner; E H Birkenmeier; O Ben-Zeev; M C Schotz; H O Sweet; M T Davisson; J I Gordon
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

7.  Lipin1 is a key factor for the maturation and maintenance of adipocytes in the regulatory network with CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma 2.

Authors:  Yoo-Kyung Koh; Min-Young Lee; Jae-Woo Kim; Minji Kim; Jong-Seok Moon; Yoo-Jung Lee; Yong-Ho Ahn; Kyung-Sup Kim
Journal:  J Biol Chem       Date:  2008-10-16       Impact factor: 5.157

8.  The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme.

Authors:  Gil-Soo Han; Wen-I Wu; George M Carman
Journal:  J Biol Chem       Date:  2006-02-08       Impact factor: 5.157

9.  Phosphatidic acid mediates demyelination in Lpin1 mutant mice.

Authors:  Karim Nadra; Anne-Sophie de Preux Charles; Jean-Jacques Médard; William T Hendriks; Gil-Soo Han; Sandra Grès; George M Carman; Jean-Sébastien Saulnier-Blache; Mark H G Verheijen; Roman Chrast
Journal:  Genes Dev       Date:  2008-06-15       Impact factor: 11.361

Review 10.  Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases.

Authors:  David N Brindley; Carlos Pilquil; Meltem Sariahmetoglu; Karen Reue
Journal:  Biochim Biophys Acta       Date:  2009-02-27
View more
  37 in total

1.  Lipin1 is required for skeletal muscle development by regulating MEF2c and MyoD expression.

Authors:  Abdulrahman Jama; Dengtong Huang; Abdullah A Alshudukhi; Roman Chrast; Hongmei Ren
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

2.  Liver-specific loss of lipin-1-mediated phosphatidic acid phosphatase activity does not mitigate intrahepatic TG accumulation in mice.

Authors:  George G Schweitzer; Zhouji Chen; Connie Gan; Kyle S McCommis; Nisreen Soufi; Roman Chrast; Mayurranjan S Mitra; Kui Yang; Richard W Gross; Brian N Finck
Journal:  J Lipid Res       Date:  2015-02-26       Impact factor: 5.922

Review 3.  Mammalian lipin phosphatidic acid phosphatases in lipid synthesis and beyond: metabolic and inflammatory disorders.

Authors:  Karen Reue; Huan Wang
Journal:  J Lipid Res       Date:  2019-02-25       Impact factor: 5.922

4.  Agpat4/Lpaatδ deficiency highlights the molecular heterogeneity of epididymal and perirenal white adipose depots.

Authors:  Emily B Mardian; Ryan M Bradley; Juan J Aristizabal Henao; Phillip M Marvyn; Katherine A Moes; Eric Bombardier; A Russell Tupling; Ken D Stark; Robin E Duncan
Journal:  J Lipid Res       Date:  2017-08-16       Impact factor: 5.922

5.  Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration.

Authors:  Andrew J Lutkewitte; George G Schweitzer; Stefanie Kennon-McGill; Melissa M Clemens; Laura P James; Hartmut Jaeschke; Brian N Finck; Mitchell R McGill
Journal:  Food Chem Toxicol       Date:  2018-03-11       Impact factor: 6.023

6.  Intestine-specific deletion of acyl-CoA:monoacylglycerol acyltransferase (MGAT) 2 protects mice from diet-induced obesity and glucose intolerance.

Authors:  David W Nelson; Yu Gao; Mei-I Yen; Chi-Liang Eric Yen
Journal:  J Biol Chem       Date:  2014-05-01       Impact factor: 5.157

7.  Rhabdomyolysis-Associated Mutations in Human LPIN1 Lead to Loss of Phosphatidic Acid Phosphohydrolase Activity.

Authors:  George G Schweitzer; Sara L Collier; Zhouji Chen; James M Eaton; Anne M Connolly; Robert C Bucelli; Alan Pestronk; Thurl E Harris; Brian N Finck
Journal:  JIMD Rep       Date:  2015-05-13

8.  Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and Atherosclerosis.

Authors:  Aimee E Vozenilek; Aaron R Navratil; Jonette M Green; David T Coleman; Cassidy M R Blackburn; Alexandra C Finney; Brenna H Pearson; Roman Chrast; Brian N Finck; Ronald L Klein; A Wayne Orr; Matthew D Woolard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12-07       Impact factor: 8.311

9.  cAMP-stimulated transcription of DGKθ requires steroidogenic factor 1 and sterol regulatory element binding protein 1.

Authors:  Kai Cai; Marion B Sewer
Journal:  J Lipid Res       Date:  2013-04-22       Impact factor: 5.922

Review 10.  Lipins, lipinopathies, and the modulation of cellular lipid storage and signaling.

Authors:  Lauren S Csaki; Jennifer R Dwyer; Loren G Fong; Peter Tontonoz; Stephen G Young; Karen Reue
Journal:  Prog Lipid Res       Date:  2013-04-17       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.